Article Details

Celgene and Exscientia sign AI drug discovery deal in oncology and autoimmunity

Retrieved on: 2019-03-21 20:45:00

Tags for this article:

Click the tags to see associated articles and topics

Celgene and Exscientia sign AI drug discovery deal in oncology and autoimmunity. View article details on hiswai:

Excerpt

<div>... Berg, which has collaborations with AstraZeneca and Sanofi, while MSD is working with Numerate, and <b>Insilico Medicine</b> is working with GSK.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo